Skip to product information
1 of 1
IHC of pTau Phospho/Thr 181 on a FFPE Alzheimer's disease Brain tissue
Home Product pTau Phospho\Thr 181

pTau Phospho\Thr 181 (BSB-176)

US
IVD-CE
Europe
IVD-CE
International
IVD-CE
Size
Contact for price View full details

Product Information

Summary & Explanation

{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"Tau is a phosphorylated protein, containing 85 potential serine (S), threonine (T), and tyrosine (Y) phosphorylation sites. Both the phosphorylation status and isoform expression of tau are developmentally regulated and both are important factors for cytoskeletal plasticity during embryogenesis and early development. Despite the significant heterogeneity that exists between and within the various tauopathies, the deposited tau in pathological lesions is invariably highly phosphorylated.\n Characteristic accumulations of highly phosphorylated tau protein (Thr 181) aggregates are found in several neurodegenerative tauopathies including Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and some forms of frontotemporal lobar dementia (FTLD-tau)."}]}]}

Antibody Type

Mouse Monoclonal

Clone

BSB-176

Isotype

IgG1κ

Localization

Perinuclear, Cytoplasmic

Dilution

1:25-1:50

Species Reactivity

Human

Immunogen

Synthetic peptide of the human pT181 Tau protein.